Cystic Fibrosis Clinical Trial
Official title:
Measuring and Improving Coproduction Using coopeRATE: A Before-and-after Study in Adult Cystic Fibrosis Care
Verified date | July 2020 |
Source | Dartmouth-Hitchcock Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to identify new methods of measuring and improving collaborative goal setting between patients and clinicians in adult cystic fibrosis care.
Status | Terminated |
Enrollment | 280 |
Est. completion date | March 16, 2020 |
Est. primary completion date | March 16, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Have a diagnosis of cystic fibrosis 2. Are 18 years of age or older 3. Can read and write in English 4. Are attending a participating site for a routine cystic fibrosis care visit 5. Have already consented to participate in the Cystic Fibrosis Foundation Patient Registry 6. Allow study researchers to access their Cystic Fibrosis Foundation Patient Registry information and link it to their study data 7. Have not previously participated in the study Exclusion Criteria: 1. Do not have a diagnosis of cystic fibrosis 2. Are less than 18 years of age 3. Cannot read and write in English 4. Are not attending a participating site for a routine cystic fibrosis care visit 5. Have not already consented to participate in the Cystic Fibrosis Foundation Patient Registry 6. Do not allow study researchers to access their Cystic Fibrosis Foundation Patient Registry information and link it to their study data 7. Have previously participated in the study |
Country | Name | City | State |
---|---|---|---|
United States | Boston Children's Hospital | Boston | Massachusetts |
United States | University of Virginia | Charlottesville | Virginia |
United States | University of Texas Southwestern Medical Center | Dallas | Texas |
United States | National Jewish Health | Denver | Colorado |
United States | University of Kansas Medical Center | Kansas City | Kansas |
United States | Dartmouth-Hitchcock Medical Center / Dartmouth-Hitchcock Manchester | Lebanon | New Hampshire |
United States | University of Nebraska Medical Center / Nebraska Medical Center | Omaha | Nebraska |
United States | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania |
United States | University of California San Diego | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center | Boston Children’s Hospital, Cystic Fibrosis Foundation |
United States,
Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G. The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2014 Jan 3;16(1):e2. doi: 10.2196/jmir.3085. Erratum in: J Med Internet Res. 2015;17(2):e32. J Med Internet Res. 2015;17(2):e32. — View Citation
Dalcin AT, Jerome GJ, Fitzpatrick SL, Louis TA, Wang NY, Bennett WL, Durkin N, Clark JM, Daumit GL, Appel LJ, Coughlin JW. Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER Trial. Obes Sci Pract. 2015 Oct;1(1):23-32. Epub 2015 Sep 9. — View Citation
Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct;93(1):102-7. doi: 10.1016/j.pec.2013.05.009. Epub 2013 Jun 12. — View Citation
Makoul G, Krupat E, Chang CH. Measuring patient views of physician communication skills: development and testing of the Communication Assessment Tool. Patient Educ Couns. 2007 Aug;67(3):333-42. Epub 2007 Jun 18. — View Citation
Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014 Nov;67(11):1265-73. doi: 10.1016/j.jclinepi.2014.06.009. Epub 2014 Aug 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Description of goals discussed during the visit | Patient-reported goals discussed during the health care visit (if goals were discussed), assessed using a single item with open-text response format. | Immediately after the health care visit (Day 0) | |
Other | Preference for discussing goals | Patient-reported preference for discussing goals with their clinician during the health care visit, assessed using a single item with multiple choice (single answer) format. | Immediately after the health care visit (Day 0) | |
Other | Use of coopeRATE Prompt | Patient-reported use of the coopeRATE Prompt intervention during the health care visit, assessed using a single item with multiple choice (single answer) format. | Immediately after the health care visit (Day 0) - Phase 2 only | |
Other | Reason(s) for not using coopeRATE Prompt (patient) | Patient-reported reason(s) for not using the coopeRATE Prompt intervention during the health care visit (if intervention was not used), assessed using a single item with multiple choice (multiple answer) format. | Immediately after the health care visit (Day 0) - Phase 2 only | |
Other | Perceived helpfulness of coopeRATE Prompt | Patient-reported perceived helpfulness of the coopeRATE Prompt intervention (if intervention was used), assessed using a single adapted item (Dalcin et al., 2015). The item is rated on a 5-point scale ranging from 0 ('Not at all helpful') to 4 ('Extremely helpful'). | Immediately after the health care visit (Day 0) - Phase 2 only | |
Other | Way(s) in which coopeRATE Prompt helpful | Patient-reported way(s) in which the coopeRATE Prompt intervention was helpful (if intervention was perceived to be at least slightly helpful), assessed using a single item with multiple choice (multiple answer) format. | Immediately after the health care visit (Day 0) - Phase 2 only | |
Other | People seen during health care visit | Patient-reported people seen (e.g., doctor, nurse) during the health care visit, assessed using a single item with multiple choice (multiple answer) format. | Immediately after the health care visit (Day 0) | |
Other | History with people seen during health care visit | Patient-reported history with people seen during the health care visit, assessed using a single item with multiple choice (single answer) format. | Immediately after the health care visit (Day 0) | |
Other | Type of health care visit | Patient-reported type of health care visit, assessed using a single item with multiple choice (multiple answer) format. | Immediately after the health care visit (Day 0) | |
Other | Participation in other research | Patient-reported participation in other research studies during the health care visit, assessed using two single items with multiple choice (single answer) format. | Immediately after the health care visit (Day 0) | |
Other | Receipt of coopeRATE Prompt | Clinician-reported receipt of the coopeRATE Prompt intervention, assessed using a single item with multiple choice (single answer) format. | Within one month after completion of Phase 2 patient data collection | |
Other | Frequency of use of coopeRATE Prompt | Clinician-reported frequency of using the coopeRATE Prompt intervention to guide conversations with patients (if intervention was ever received), assessed using a single item with multiple choice (single answer) format. | Within one month after completion of Phase 2 patient data collection | |
Other | Reason(s) for not using coopeRATE Prompt (clinician) | Clinician-reported reason(s) for not using the coopeRATE Prompt intervention to guide conversations with patients (if intervention was not always used), assessed using two single items with multiple choice (multiple answer) format. | Within one month after completion of Phase 2 patient data collection | |
Other | Frequency of coopeRATE Prompt improving conversations | Clinician-reported frequency of the coopeRATE Prompt intervention improving the quality of conversations with patients (if intervention was ever used), assessed using a single item with multiple choice (single answer) format. | Within one month after completion of Phase 2 patient data collection | |
Other | Frequency of coopeRATE Prompt increasing consultation time | Clinician-reported frequency of the coopeRATE Prompt intervention increasing consultation time with patients (if intervention was ever used), assessed using a single item with multiple choice (single answer) format. | Within one month after completion of Phase 2 patient data collection | |
Primary | Collaborative goal setting | A new 3-item patient-reported measure under evaluation to assess collaborative goal setting between a patient and their clinician during the health care visit. Each item is rated on a 4-point scale ranging from 0 ('Strongly disagree') to 3 ('Strongly agree'), with an additional 'Not sure' option. Scoring method is to be determined. | Immediately after the health care visit (Day 0) | |
Secondary | Shared decision-making | Patient-reported shared decision-making during the health care visit, assessed using the 3-item collaboRATE measure (Elwyn et al., 2013; Barr et al., 2014). Each item is rated on a 10-point scale ranging from 0 ('No effort was made') to 9 ('Every effort was made'). Respondent's are assigned a score of 1 if every item is rated 'Every effort was made' and a score of 0 for all other response combinations. | Immediately after the health care visit (Day 0) | |
Secondary | Interpersonal and communication skills | Patient-reported interpersonal and communication skills of their clinician during the health care visit, assessed using a 14-item version of the Communication Assessment Tool (CAT) (Makoul, Krupat, & Chang, 2007). Each item is rated on a 5-point scale ranging from 1 ('Poor') to 5 ('Excellent'). A respondent's total scale score is the percentage of items rated as 'Excellent'. | Immediately after the health care visit (Day 0) | |
Secondary | Self-efficacy to manage chronic disease | Patient-reported self-efficacy for managing their chronic disease immediately following the health care visit, assessed using an adapted version of the 6-item Self-Efficacy to Manage Chronic Disease Scale (Ritter & Lorig, 2014). Each item is rated on a 10-point scale ranging from 1 ('Not at all confident') to 10 ('Totally confident'). A respondent's total score is the mean of all item responses. | Immediately after the health care visit (Day 0) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |